AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Efoglim M 3mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Oldmed Healthcare Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Efoglim M 3mg/500mg Tablet SR

DiaBeta Duo 3mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. DiaBeta Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as premature discontinuation, without consulting your doctor, risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular mealtimes and carry a readily available fast-acting glucose source, such as sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be minimized. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women must consult their doctor prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Efoglim M 3mg/500mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Efoglim M 3mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Efoglim M 3mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Efoglim M 3mg/500mg Extended-Release Tablets should be taken with a meal.

Common Side effects of Efoglim M 3mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Efoglim M 3mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Efoglim M 3mg/500mg Extended-Release tablets with food.

How Efoglim M 3mg/500mg Tablet SR works:

Efoglim M SR tablets (3mg/500mg) combine the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Efoglim M 3mg/500mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Efoglim M 3mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is recommended.

Breast feedingBreast feedingUNSAFE

Extended-release Efoglim M 3mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Efoglim M 3mg/500mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is necessary. Efoglim M 3mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Efoglim M 3mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is essential. For individuals with mild to moderate hepatic dysfunction, initiation should involve a reduced Efoglim M 3mg/500mg Tablet SR dose; however, it's contraindicated in those with severe liver disease.

What if you forget to take Efoglim M 3mg/500mg Tablet SR :

Should you forget to take your Efoglim M 3mg/500mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Efoglim M 3mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Efoglim M 3mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Efoglim M 3mg/500mg Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Efoglim M 3mg/500mg Tablet SR and seek immediate medical attention.
Efoglim M 3mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Efoglim M 3mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Efoglim M 3mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Efoglim M 3mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Efoglim M 3mg/500mg SR tablets with alcohol is unsafe. Alcohol may exacerbate the drug's effects, potentially causing dangerously low blood sugar (hypoglycemia) and raising the risk of lactic acidosis.
Efoglim M 3mg/500mg Table...
64
MRP 74
13% off